{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T19:16:04Z","timestamp":1773170164181,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04575-x","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:27:30Z","timestamp":1773106050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Usefulness of steroid profiling in the diagnosis of primary Aldosteronism a systematic review"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0310-7095","authenticated-orcid":false,"given":"Paola","family":"Parra Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Artiles Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Mart\u00edn Rojas-Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregori","family":"Casals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imanol","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia A.","family":"Hanzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-0072","authenticated-orcid":false,"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"4575_CR1","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1210\/CLINEM\/DGAC460","volume":"107","author":"P Mulatero","year":"2022","unstructured":"P. Mulatero, C. Bertello, F. Veglio, S. Monticone, Approach to the patient on antihypertensive therapy: screen for primary aldosteronism. J. Clin. Endocrinol. Metab. 107, 3175\u20133181 (2022). https:\/\/doi.org\/10.1210\/CLINEM\/DGAC460","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4575_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata et al., The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 1889\u20131916 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4575_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cjca.2020.05.013","volume":"37","author":"D Sam","year":"2021","unstructured":"D. Sam, G.A. Kline, B. So, S.J. Przybojewski, A.A. Leung, Unilateral disease is common in patients with primary aldosteronism without adrenal nodules. Can. J. Cardiol. 37, 269\u2013275 (2021). https:\/\/doi.org\/10.1016\/j.cjca.2020.05.013","journal-title":"Can. J. Cardiol."},{"key":"4575_CR4","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"G.P. Rossi, G. Bernini, C. Caliumi, G. Desideri, B. Fabris, C. Ferri et al., A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48, 2293\u20132300 (2006). https:\/\/doi.org\/10.1016\/j.jacc.2006.07.059","journal-title":"J. Am. Coll. Cardiol."},{"key":"4575_CR5","doi-asserted-by":"publisher","unstructured":"A. Muth, O. Ragnarsson, G. Johannsson, B. W\u00e4ngberg, Systematic review of surgery and outcomes in patients with primary aldosteronism. Br. J. Surg. 102 (2015). https:\/\/doi.org\/10.1002\/BJS.9744","DOI":"10.1002\/BJS.9744"},{"key":"4575_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/S12020-024-03751-1","volume":"85","author":"M Araujo-Castro","year":"2024","unstructured":"M. Araujo-Castro, J.G. Ruiz-S\u00e1nchez, P. Parra Ram\u00edrez, P. Mart\u00edn Rojas-Marcos, A. Aguilera-Saborido, J.F. G\u00f3mez Cerezo et al., Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish societies involved in the management of primary aldosteronism. Endocrine. 85, 99\u2013121 (2024). https:\/\/doi.org\/10.1007\/S12020-024-03751-1","journal-title":"Endocrine"},{"key":"4575_CR7","doi-asserted-by":"publisher","unstructured":"G.P. Rossi, V. Bisogni, A.V. Bacca, A. Belfiore, M. Cesari, A. Concistr\u00e8 et al., The 2020 Italian society of arterial hypertension (SIIA) practical guidelines for the management of primary aldosteronism. Int. J. Cardiol. Hypertens. 2020;5. https:\/\/doi.org\/10.1016\/j.ijchy.2020.100029","DOI":"10.1016\/j.ijchy.2020.100029"},{"key":"4575_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/ENDOCRJ.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"T. Nishikawa, M. Omura, F. Satoh, H. Shibata, K. Takahashi, N. Tamura et al., Guidelines for the diagnosis and treatment of primary aldosteronism\u2013the Japan endocrine society 2009. Endocr. J. 58, 711\u2013721 (2011). https:\/\/doi.org\/10.1507\/ENDOCRJ.EJ11-0133","journal-title":"Endocr. J."},{"key":"4575_CR9","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/HJH.0000000000000168","volume":"32","author":"SB Nikolic","year":"2014","unstructured":"S.B. Nikolic, J.E. Sharman, M.J. Adams, L.M. Edwards, Metabolomics in hypertension. J. Hypertens. 32, 1159\u20131169 (2014). https:\/\/doi.org\/10.1097\/HJH.0000000000000168","journal-title":"J. Hypertens."},{"key":"4575_CR10","doi-asserted-by":"publisher","unstructured":"A. Lana, K. Alexander, A. Castagna, A. D\u2019Alessandro, F. Morandini, F. Pizzolo et al., Urinary metabolic signature of primary aldosteronism: gender and Subtype-Specific alterations. Proteom. Clin. Appl. 13 (2019). https:\/\/doi.org\/10.1002\/PRCA.201800049","DOI":"10.1002\/PRCA.201800049"},{"key":"4575_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/S12020-022-03122-8","volume":"78","author":"M Araujo-Castro","year":"2022","unstructured":"M. Araujo-Castro, M. Paja Fano, M. Gonz\u00e1lez Boillos, B. Pla Peris, E. Pascual-Corrales, A.M. Garc\u00eda Cano et al., Adrenal venous sampling in primary aldosteronism: experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register). Endocrine. 78, 363\u2013372 (2022). https:\/\/doi.org\/10.1007\/S12020-022-03122-8","journal-title":"Endocrine"},{"key":"4575_CR12","doi-asserted-by":"publisher","unstructured":"G. Ceolotto, G. Antonelli, G. Maiolino, M. Cesari, G. Rossitto, V. Bisogni et al., Androstenedione and 17-\u03b1-Hydroxyprogesterone are better indicators of adrenal vein sampling selectivity than Cortisol. Hypertens (Dallas, Tex 1979) 2017;70:342\u2013346. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09415","DOI":"10.1161\/HYPERTENSIONAHA.117.09415"},{"key":"4575_CR13","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1161\/HYPERTENSIONAHA.113.01601","volume":"62","author":"T Dekkers","year":"2013","unstructured":"T. Dekkers, J. Deinum, L.J. Schultzekool, D. Blondin, O. Vonend, A.R.R.M. Hermus et al., Plasma metanephrine for assessing the selectivity of adrenal venous sampling. Hypertens. (Dallas Tex. 1979. 62, 1152\u20131157 (2013). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01601","journal-title":"Hypertens. (Dallas Tex. 1979"},{"key":"4575_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2217\/IJE-2016-0020","volume":"4","author":"N Nilubol","year":"2017","unstructured":"N. Nilubol, S.J. Soldin, D. Patel, M. Rwenji, J. Gu, L.S. Masika et al., 11-Deoxycortisol May be superior to cortisol in confirming a successful adrenal vein catheterization without cosyntropin: a pilot study. Int. J. Endocr. Oncol. 4, 75\u201383 (2017). https:\/\/doi.org\/10.2217\/IJE-2016-0020","journal-title":"Int. J. Endocr. Oncol."},{"key":"4575_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/J.STEROIDS.2018.04.002","volume":"134","author":"H Li","year":"2018","unstructured":"H. Li, X. Zhang, S. Shen, Y. Zhang, W. Zhang, W. Feng et al., Adrenal androgen measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism. Steroids. 134, 16\u201321 (2018). https:\/\/doi.org\/10.1016\/J.STEROIDS.2018.04.002","journal-title":"Steroids"},{"key":"4575_CR16","doi-asserted-by":"publisher","unstructured":"G. Ceolotto, G. Antonelli, B. Caroccia, M. Battistel, G. Barbiero, M. Plebani et al., Comparison of Cortisol, Androstenedione and metanephrines to assess selectivity and lateralization of adrenal vein sampling in primary aldosteronism. J. Clin. Med. 10 (2021). https:\/\/doi.org\/10.3390\/JCM10204755","DOI":"10.3390\/JCM10204755"},{"key":"4575_CR17","doi-asserted-by":"publisher","unstructured":"A.F. Turcu, T. Wannachalee, A. Tsodikov, A.T. Nanba, J. Ren, J.J. Shields et al., Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism Subtyping. Hypertens (Dallas, Tex 1979) 2020;75:183\u2013192. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.13866","DOI":"10.1161\/HYPERTENSIONAHA.119.13866"},{"key":"4575_CR18","doi-asserted-by":"publisher","unstructured":"A.S. Powlson, M. Gurnell, M.J. Brown, P. AS, M G, MJ B. Nuclear imaging in the diagnosis of primary aldosteronism. 22. Curr Opin Endocrinol Diabetes Obes; 2015. https:\/\/doi.org\/10.1097\/MED.0000000000000148","DOI":"10.1097\/MED.0000000000000148"},{"key":"4575_CR19","unstructured":"Checklists - STROBE n, d. https:\/\/www.strobe-statement.org\/checklists\/ (accessed January 23, 2025)"},{"key":"4575_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jc.2011-2384","volume":"97","author":"P Mulatero","year":"2012","unstructured":"P. Mulatero, Di S.M. Cella, S. Monticone, D. Schiavone, M. Manzo, G. Mengozzi et al., 18-Hydroxycorticosterone, 18-Hydroxycortisol, and 18-Oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J. Clin. Endocrinol. Metab. 97, 881\u2013889 (2012). https:\/\/doi.org\/10.1210\/jc.2011-2384","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4575_CR21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.11465","volume":"72","author":"LS Meyer","year":"2018","unstructured":"L.S. Meyer, X. Wang, E. Su\u0161nik, J. Burrello, A. Burrello, I. Castellano et al., Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism. Hypertension. 72, 650\u2013657 (2018). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11465","journal-title":"Hypertension"},{"key":"4575_CR22","doi-asserted-by":"publisher","unstructured":"Y. Nakamura, F. Satoh, R. Morimoto, M. Kudo, K. Takase, C.E. Gomez-Sanchez et al., 18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism. J. Clin. Endocrinol. Metab. 96 (2011). https:\/\/doi.org\/10.1210\/JC.2010-2785","DOI":"10.1210\/JC.2010-2785"},{"key":"4575_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/J.JSBMB.2014.10.006","volume":"145","author":"M Peitzsch","year":"2015","unstructured":"M. Peitzsch, T. Dekkers, M. Haase, F.C.G.J. Sweep, I. Quack, G. Antoch et al., An LC-MS\/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism. J. Steroid Biochem. Mol. Biol. 145, 75\u201384 (2015). https:\/\/doi.org\/10.1016\/J.JSBMB.2014.10.006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"4575_CR24","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","volume":"65","author":"F Satoh","year":"2015","unstructured":"F. Satoh, R. Morimoto, Y. Ono, Y. Iwakura, K. Omata, M. Kudo et al., Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism. Hypertension. 65, 1096\u20131102 (2015). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04453","journal-title":"Hypertension"},{"key":"4575_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1210\/JCEM-64-4-771","volume":"64","author":"S Lewicka","year":"1987","unstructured":"S. Lewicka, J. Winter, K. Bige, V. Bokkenheuser, P. Vecsei, S. Abdelhamid et al., 21-Deoxyaldosterone excretion in patients with primary aldosteronism and 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 64, 771\u2013777 (1987). https:\/\/doi.org\/10.1210\/JCEM-64-4-771","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4575_CR26","doi-asserted-by":"publisher","unstructured":"M. Stowasser, A.W. Bachmann, T.J. Tunny, R.D. Gordon, Production of 18-oxo-cortisol in subtypes of primary aldosteronism. Clin. Exp. Pharmacol. Physiol., vol. 23, Clin Exp Pharmacol Physiol; 1996, pp. 591\u20133. https:\/\/doi.org\/10.1111\/j.1440-1681.1996.tb02789.x","DOI":"10.1111\/j.1440-1681.1996.tb02789.x"},{"key":"4575_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1210\/jcem.76.4.8473399","volume":"76","author":"S Ulick","year":"1993","unstructured":"S. Ulick, J.D. Blumenfeld, S.A. Atlas, J.Z. Wang, E.D. Vaughan, The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metab. 76, 873\u2013878 (1993). https:\/\/doi.org\/10.1210\/jcem.76.4.8473399","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4575_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/0039-128X(91)90015-N","volume":"56","author":"Y Takeda","year":"1991","unstructured":"Y. Takeda, K. Bige, T. Iwuanyanwu, S. Lewicka, P. Vecsei, S. Abdelhamid et al., Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism. Steroids. 56, 566\u2013570 (1991). https:\/\/doi.org\/10.1016\/0039-128X(91)90015-N","journal-title":"Steroids"},{"issue":"Pt 3","key":"4575_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/000456328902600303","volume":"26","author":"R Lapworth","year":"1989","unstructured":"R. Lapworth, F. Short, V.H.T. James, 18-Hydroxycorticosterone as a marker for primary hyperaldosteronism. Ann. Clin. Biochem. 26(Pt 3), 227\u2013232 (1989). https:\/\/doi.org\/10.1177\/000456328902600303","journal-title":"Ann. Clin. Biochem."},{"key":"4575_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/CEN.14691","volume":"97","author":"M Viukari","year":"2022","unstructured":"M. Viukari, E. Kokko, I. P\u00f6rsti, H. Leijon, T. Vesterinen, T. Hinkka et al., Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling. Clin. Endocrinol. (Oxf). 97, 241\u2013249 (2022). https:\/\/doi.org\/10.1111\/CEN.14691","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4575_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1530\/EJE.1.01922","volume":"152","author":"RM Reynolds","year":"2005","unstructured":"R.M. Reynolds, L.A. Shakerdi, K. Sandhu, A.M. Wallace, P.J. Wood, B.R. Walker, The utility of three different methods for measuring urinary 18-hydroxycortisol in the differential diagnosis of suspected primary hyperaldosteronism. Eur. J. Endocrinol. 152, 903\u2013907 (2005). https:\/\/doi.org\/10.1530\/EJE.1.01922","journal-title":"Eur. J. Endocrinol."},{"key":"4575_CR32","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0895-7061(03)00858-6","volume":"16","author":"S Abdelhamid","year":"2003","unstructured":"S. Abdelhamid, R. Blomer, G. Hommel, D. Haack, S. Lewicka, P. Fiegel et al., Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study. Am. J. Hypertens. 16, 522\u2013530 (2003). https:\/\/doi.org\/10.1016\/S0895-7061(03)00858-6","journal-title":"Am. J. Hypertens."},{"key":"4575_CR33","doi-asserted-by":"publisher","first-page":"E1181","DOI":"10.1210\/CLINEM\/DGAB751","volume":"107","author":"K Berke","year":"2022","unstructured":"K. Berke, G. Constantinescu, J. Masjkur, O. Kimpel, U. Dischinger, M. Peitzsch et al., Plasma steroid profiling in patients with adrenal incidentaloma. J. Clin. Endocrinol. Metab. 107, E1181\u2013E1192 (2022). https:\/\/doi.org\/10.1210\/CLINEM\/DGAB751","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4575_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1620\/TJEM.124.367","volume":"124","author":"M Ojima","year":"1978","unstructured":"M. Ojima, M. Ojima, M. Aida, A. Kambegawa, Simultaneous determination of plasma 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone, and aldosterone in man. Tohoku J. Exp. Med. 124, 367\u2013379 (1978). https:\/\/doi.org\/10.1620\/TJEM.124.367","journal-title":"Tohoku J. Exp. Med."},{"key":"4575_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/BF01479835","volume":"56","author":"W Pellnitz","year":"1978","unstructured":"W. Pellnitz, M. Sch\u00f6nesh\u00f6fer, W. Oelkers, Differentiation between subtypes of primary hyperaldosteronism by multiple steroid measurement after dexamethasone administration. Klin. Wochenschr. 56, 855\u2013858 (1978). https:\/\/doi.org\/10.1007\/BF01479835","journal-title":"Klin. Wochenschr"},{"key":"4575_CR36","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3803\/ENM.2021.1149","volume":"36","author":"EJ Ku","year":"2021","unstructured":"E.J. Ku, C. Lee, J. Shim, S. Lee, K.A. Kim, S.W. Kim et al., Metabolic subtyping of adrenal tumors: prospective Multi-Center cohort study in Korea. Endocrinol. Metab. (Seoul Korea). 36, 1131\u20131141 (2021). https:\/\/doi.org\/10.3803\/ENM.2021.1149","journal-title":"Endocrinol. Metab. (Seoul Korea)"},{"key":"4575_CR37","doi-asserted-by":"publisher","unstructured":"S. Reel, P.S. Reel, Z. Erlic, L. Amar, A. Pecori, C.K. Larsen et al., Predicting hypertension subtypes with machine learning using targeted metabolites and their ratios. Metabolites 2022;12. https:\/\/doi.org\/10.3390\/METABO12080755","DOI":"10.3390\/METABO12080755"},{"key":"4575_CR38","doi-asserted-by":"publisher","unstructured":"P.S. Reel, S. Reel, van J.C. Kralingen, K. Langton, K. Lang, Z. Erlic et al., Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study. EBioMedicine 2022;84. https:\/\/doi.org\/10.1016\/J.EBIOM.2022.104276","DOI":"10.1016\/J.EBIOM.2022.104276"},{"key":"4575_CR39","doi-asserted-by":"publisher","unstructured":"N.G. Bliziotis, L.A.J. Kluijtmans, G.H. Tinnevelt, P. Reel, S. Reel, K. Langton et al., Preanalytical pitfalls in untargeted plasma nuclear magnetic resonance metabolomics of endocrine hypertension. Metabolites 2022;12. https:\/\/doi.org\/10.3390\/METABO12080679","DOI":"10.3390\/METABO12080679"},{"key":"4575_CR40","doi-asserted-by":"publisher","unstructured":"Y. Chen, H. Wang, K. Wang, G. Zhu, Z. Yang, M. Wang et al., Serum metabolomic patterns in patients with Aldosterone-Producing adenoma. Front. Mol. Biosci. 2022;9. https:\/\/doi.org\/10.3389\/FMOLB.2022.816469","DOI":"10.3389\/FMOLB.2022.816469"},{"key":"4575_CR41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jsbmb.2019.01.008","volume":"189","author":"Y Yang","year":"2019","unstructured":"Y. Yang, J. Burrello, A. Burrello, G. Eisenhofer, M. Peitzsch, M. Tetti et al., Classification of microadenomas in patients with primary aldosteronism by steroid profiling. J. Steroid Biochem. Mol. Biol. 189, 274\u2013282 (2019). https:\/\/doi.org\/10.1016\/j.jsbmb.2019.01.008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"4575_CR42","doi-asserted-by":"publisher","unstructured":"R. Knuchel, Z. Erlic, S. Gruber, L. Amar, C.K. Larsen, A.P. Gimenez-Roqueplo et al., Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertension. Front. Endocrinol. (Lausanne). 15 (2024). https:\/\/doi.org\/10.3389\/FENDO.2024.1370525","DOI":"10.3389\/FENDO.2024.1370525"},{"key":"4575_CR43","doi-asserted-by":"publisher","unstructured":"W. Arlt, K. Lang, A.J. Sitch, A.S. Dietz, Y. Rhayem, I. Bancos et al., Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism. JCI Insight 2017;2. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.93136","DOI":"10.1172\/JCI.INSIGHT.93136"},{"key":"4575_CR44","doi-asserted-by":"publisher","unstructured":"J. Noh, C. Lee, J.H. Kim, S.W. Myung, M.H. Choi, LC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines. J. Lipid Res. 64 (2023). https:\/\/doi.org\/10.1016\/J.JLR.2023.100453","DOI":"10.1016\/J.JLR.2023.100453"},{"key":"4575_CR45","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","volume":"62","author":"G Eisenhofer","year":"2016","unstructured":"G. Eisenhofer, T. Dekkers, M. Peitzsch, A.S. Dietz, M. Bidlingmaier, M. Treitl et al., Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism. Clin. Chem. 62, 514\u2013524 (2016). https:\/\/doi.org\/10.1373\/clinchem.2015.251199","journal-title":"Clin. Chem."},{"key":"4575_CR46","doi-asserted-by":"publisher","unstructured":"A. Prete, K. Lang, D. Pavlov, Y. Rhayem, A.J. Sitch, A.S. Franke et al., Urine steroid metabolomics as a diagnostic tool in primary aldosteronism. J. Steroid Biochem. Mol. Biol. 2024;237. https:\/\/doi.org\/10.1016\/J.JSBMB.2023.106445","DOI":"10.1016\/J.JSBMB.2023.106445"},{"key":"4575_CR47","doi-asserted-by":"publisher","first-page":"E3969","DOI":"10.1210\/clinem\/dgab420","volume":"106","author":"Y Tezuka","year":"2021","unstructured":"Y. Tezuka, K. Ishii, L. Zhao, Y. Yamazaki, R. Morimoto, H. Sasano et al., ACTH stimulation maximizes the accuracy of peripheral steroid profiling in primary aldosteronism subtyping. J. Clin. Endocrinol. Metab. 106, E3969\u2013E3978 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgab420","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4575_CR48","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/S41440-023-01347-2","volume":"46","author":"YL Chang","year":"2023","unstructured":"Y.L. Chang, G.Y. Chen, B.C. Lee, P.T. Chen, K.L. Liu, C.C. Chang et al., Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC-MS\/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol. Hypertens. Res. 46, 1983\u20131994 (2023). https:\/\/doi.org\/10.1038\/S41440-023-01347-2","journal-title":"Hypertens. Res."},{"key":"4575_CR49","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1210\/CLINEM\/DGAA954","volume":"106","author":"Z Erlic","year":"2021","unstructured":"Z. Erlic, P. Reel, S. Reel, L. Amar, A. Pecori, C.K. Larsen et al., Targeted metabolomics as a tool in discriminating endocrine from primary hypertension. J. Clin. Endocrinol. Metab. 106, 1111\u20131128 (2021). https:\/\/doi.org\/10.1210\/CLINEM\/DGAA954","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4575_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12020-020-02544-6","volume":"72","author":"M Araujo-Castro","year":"2020","unstructured":"M. Araujo-Castro, P. Valderr\u00e1bano, H.F. Escobar-Morreale, F.A. Hanzu, G. Casals, Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature Rev. Endocr. 72, 40\u201348 (2020). https:\/\/doi.org\/10.1007\/s12020-020-02544-6","journal-title":"Literature Rev. Endocr."},{"key":"4575_CR51","doi-asserted-by":"publisher","unstructured":"S. Karashima, I. Osaka, Rapidity and precision of steroid hormone measurement. J. Clin. Med. 11 (2022). https:\/\/doi.org\/10.3390\/JCM11040956","DOI":"10.3390\/JCM11040956"},{"key":"4575_CR52","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-17-0563","volume":"178","author":"JWM Lenders","year":"2018","unstructured":"J.W.M. Lenders, T.A. Williams, M. Reincke, C.E. Gomez-Sanchez, DIAGNOSIS OF ENDOCRINE DISEASE, 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids? Eur. J. Endocrinol. 178, R1\u20139 (2018). https:\/\/doi.org\/10.1530\/EJE-17-0563","journal-title":"Eur. J. Endocrinol."},{"key":"4575_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/J.MCE.2015.11.014","volume":"422","author":"Y Nakamura","year":"2016","unstructured":"Y. Nakamura, M. Kitada, F. Satoh, T. Maekawa, R. Morimoto, Y. Yamazaki et al., Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2\/B1 and CYP17. Mol. Cell. Endocrinol. 422, 57\u201363 (2016). https:\/\/doi.org\/10.1016\/J.MCE.2015.11.014","journal-title":"Mol. Cell. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04575-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04575-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04575-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:27:35Z","timestamp":1773106055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04575-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4575"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04575-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"105"}}